Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Guangzhou Lixin Pharmaceutical Co., Ltd., established on 2003-01-08, Business scope includes research in health science projects,to develop;drug development;Business Management Consulting Services;Planning creative services;Market Research Services;Marketing Planning Service;Mechanical Technology Development Services;Chemical Engineering Research Services;Food Science and Technology Research Services;Chinese patent medicine production;Manufacturing of chemical raw materials;Manufacturing of chemical preparations;Biopharmaceutical Manufacturing;Chinese patent medicine,Chinese Herbal Pieces Wholesale;Western medicine wholesale;Biological product(No vaccine)wholesale;

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Anijen Co., Ltd. is the first bio-venture company in Gwangju and Jeonnam province. Since its establishment in 2000, it has developed peptide biomaterial process and developed quality management technology. They are making efforts to advance into the global market based on their competitiveness. In 2016, it was listed on the KOSDAQ market based on its proprietary peptide biomaterials and new drug development technology. They are supplying Peptide Medicinal Materials of high quality, which have been approved by GMP for the first time in Korea, at a reasonable price in the peptides drug materials market, which is dominated by a small number of companies worldwide. This stabilizes the supply price of peptide drug raw materials, And contribute to the promotion of public health.

Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY.

Xechem, Inc. is an American private company involved in medicinal chemicals and botanical products.

Beijing Beike Deyuan Biomedical Technology Co., Ltd., established on 2015-12-07, Business scope includes biological targets,Drug molecule design and screening,medicinal chemistry,Biotechnology,Biomedical Big Data,Technology development of health and disease prevention and early warning,technical consulting,Technology Promotion,technology transfer,Technical Training;account Serive;Health Advisory(Except for medical treatment activities subject to approval);Sales of chemical products(Does not contain dangerous chemicals and a class of precursor chemicals),cosmetic,computer,Software and Auxiliary Equipment;Basic software service;Application software service;software consulting;sell food.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Zhejiang Sixian Pharmaceutical Co., Ltd., established on 1999-11-22, Business scope includes licensed projects:pharmaceutical production;Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);Food Additive Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Sichuan Thinking Kangrui Pharmaceutical Co., Ltd., established on 2016-03-16, Business scope includes sales:medicine;basic medical research,clinical research,pharmaceutical research,Research on new anticancer drugs,Clinical research of new anticancer drugs;Import and export of goods and technology. (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Shandong Xingrui Biotechnology Co., Ltd., established on 2014-03-27, The scope of business includes the development of new technologies for biological cell incubation,Biological cell and gene related technology development,Technical testing,Technical Services,technology transfer,Promotion and related technical consultation;Provide medical aesthetic technical services;sell cosmetics,skin care products,Instrumentation,medical instruments,Laboratory Reagent Consumables;Undertake indoor and outdoor decoration and decoration projects,civil Engineering,Waterproofing,plumbing(without pressure piping),Indoor and outdoor insulation engineering construction.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.

Raven biotechnologies, Inc., a biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. Its lead product candidate, RAV12, targets adenocarcinomas and used for the treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is based in South San Francisco, California. As of July 17, 2008, Raven Biotechnologies, Inc. operates as a subsidiary of MacroGenics, Inc.